Sleep Disorders Trial, Recruiting (NCT06117579)

Sleep Disorders Trial, Recruiting NCT06117579 Sponsor: Centre Hospitalier Régional d'Orléans Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06117579 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) with a severity score of 5 or more on a standard sleep test, and whose condition requires CPAP treatment (a breathing machine used during sleep)

Who may not be able to join:

People whose sleep apnea is caused by a neurological (brain or nervous system) condition, or is a mixed type (confirm with trial site)
People for whom CPAP treatment is not medically suitable, or who do not wish to use it
People who have cognitive disorders (conditions affecting memory, thinking, or understanding)
People who are under legal guardianship or curatorship (where another person has been appointed to make decisions on their behalf)
People who are under court-ordered legal protection
People who are not registered with a social security scheme (confirm with trial site regarding what this means in your country)
Women who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marie DEVAUX, Dr, CHU d'Orléans

Phone: +332 38 74 40 71

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06117579

Sponsor: Centre Hospitalier Régional d'Orléans

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: +332 38 74 40 71

More information: https://clinicaltrials.gov/study/NCT06117579

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) with a severity score of 5 or more on a standard sleep test, and whose condition requires CPAP treatment (a breathing machine used during sleep)

Who may not be able to join:

People whose sleep apnea is caused by a neurological (brain or nervous system) condition, or is a mixed type (confirm with trial site)
People for whom CPAP treatment is not medically suitable, or who do not wish to use it
People who have cognitive disorders (conditions affecting memory, thinking, or understanding)
People who are under legal guardianship or curatorship (where another person has been appointed to make decisions on their behalf)
People who are under court-ordered legal protection
People who are not registered with a social security scheme (confirm with trial site regarding what this means in your country)
Women who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Régional d'Orléans

Registry

ClinicalTrials.gov

Start date

26 June 2024

Est. completion

25 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in Daytime sleepiness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov